By integrating intraoperative data from Proprio’s Paradigm™ platform with the Harms Study Group registry, the partnership ushers in a new era of quantitative AI-based spine surgery research.
SEATTLE, Nov. 12, 2025 /OrthoSpineNews/ — Proprio, the surgical technology company pioneering AI-powered surgical intelligence, today announced a partnership with Harms Study Group (HSG), a global network of distinguished surgeons dedicated to improving outcomes for children with spinal deformities. The new Proprio-HSG research collaboration will link real-time intraoperative data from Proprio’s Paradigm™ platform with HSG’s global results registry, creating a powerful new foundation for research and data quality in spinal deformity care.
By capturing objective intraoperative measurements during live surgery and connecting them to long-term outcomes data, the collaboration aims to improve the accuracy, completeness and consistency of registry data across HSG’s international hospital network. The integrated data set will support new research in surgical optimization, outcome prediction, and economics of data-driven care.
“For more than 30 years, the Harms Study Group has set the global standard for collaborative spine research,” said Gabriel Jones, CEO of Proprio. “Your registry is one of the most important data assets in medicine. With the power of AI and computer vision, Paradigm can now leverage those decades of learning, turning knowledge into a continuous learning system that measures, learns and improves with every surgery.”
The collaboration will be based on a records integration using the Proprio API, automating intraoperative data collection while reducing manual documentation. Proprio and HSG researchers will also co-author multi-center research studies and publications, expanding the evidence base for AI-powered surgical intelligence.
“This technology allows us and the physicians we work with to objectively quantify what is happening inside the operating room, something we have never had access to before,” said Dr. Firoz Miyanji, orthopedic spine surgeon at BC Children’s Hospital and vice president of research for the Harms Study Group. “Working with innovative, mission-aligned companies in this new era of AI opens the door to entirely new research questions and, ultimately, better outcomes for our patients.”
“Our mission at HSG is to accelerate discovery and raise standards in spinal deformity care,” added Michelle Marks, executive/research director of the Harms Study Group. “Integrating Paradigm intraoperative data directly improves the quality of the record and the insights it can generate.”
For more information, visit www.propriovision.com.
About Proprio
Proprio is a Seattle-based surgical technology company pioneering the future of surgery through real-time data collection and AI-powered surgical intelligence. Its Paradigm™ platform combines proprietary computer vision, light field imaging and artificial intelligence to provide continuous 3D visualization, precise intraoperative measurements and automated data capture, reducing radiation, improving efficiency and unlocking new insights for surgeons and researchers around the world.
www.propriovision.com
About the Damage Study Group (HSG)
The Harms Study Group (HSG) is a global cohort of surgeons committed to advancing the treatment of spinal deformities in children and adolescents through rigorous research and collaborative data-sharing efforts. Supported by the Getting Scoliosis Straight Foundation, HSG has spent decades shaping evidence-based care and improving patient outcomes at leading hospitals and research centers around the world.
www.harmsstudygroup.com
Own SOURCE
